Skip to main navigation
Skip to search
Skip to main content
Sultan Qaboos University House of Expertise Home
Help & FAQ
English
العربية
Home
Research units
Profiles
Research output
Projects
Equipment
Activities
Datasets
Press/Media
Prizes
Impacts
Courses
Search by expertise, name or affiliation
Retigabine ASIA medica
Majekodunmi O. Fatope
Chemistry
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Retigabine ASIA medica'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Retigabine
100%
Phase II Trials
57%
Epilepsy
42%
Dextromethorphan
28%
Pharmacokinetics
14%
Drug Resistant Epilepsy
14%
Nausea
14%
Multiple Sclerosis
14%
Sodium Channel
14%
Anticonvulsive Agent
14%
Huntington Chorea
14%
4 Aminobutyric Acid
14%
Alzheimer Disease
14%
Fatigue
14%
Toxicity
14%
Enalapril Maleate
14%
Calcium Channel
14%
Seizure
14%
Potassium Channel
14%
Ethyl Carbamate
14%
Potassium Channel Stimulating Agent
14%
Degenerative Disease
14%
Sodium Valproate
14%
Complex Partial Seizure
14%
Medicine and Dentistry
Retigabine
100%
Dextromethorphan
28%
Complex Partial Seizure
14%
Sodium Valproate
14%
Enalapril Maleate
14%
Drug Resistant Epilepsy
14%
Sodium Channel
14%
Potassium Channel
14%
Treatment of Epilepsy
14%
Antisense
14%
Potassium Channel Opener
14%
Urethan
14%
Alzheimer's Disease
14%
Gamma-Aminobutyric Acid
14%
Huntington's Disease
14%
Anticonvulsant
14%
Multiple Drug Dose
14%
Calcium Channel
14%
Toxicity
14%
Neuroscience
Retigabine
100%
Gamma-Aminobutyric Acid
14%
Potassium Channel
14%
Anticonvulsant
14%
Intractable Epilepsy
14%
Ethyl Ester
14%
Calcium Channel
14%
Sodium Channel
14%
Huntington's Disease
14%
Potassium Channel Openers
14%
Complex Partial Seizures
14%
Pharmacokinetics
14%
Agricultural and Biological Sciences
Brothers
28%
Calcium Channel
14%